Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × HER2 Positive Metastatic Breast Cancer × pyrotinib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

HER2 Positive Breast Cancer 2 Breast Neoplasms 2 Metastatic Breast Cancer in the Brain 1 HER2 Positive Metastatic Breast Cancer 1

Interventions

pyrotinib 1 Drug Therapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03691051 2023-09-25

A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

Henan Cancer Hospital

Phase 2 Unknown

HER2 Positive Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡